已知或疑似心脏结节病患者心脏磁共振右心室异常的预后价值
该系统评价与Meta分析纳入8项研究共899例已知或疑似心脏结节病患者,平均随访3.2±0.7年。右心室收缩功能障碍与复合事件(RR 3.1)及心源性猝死(RR 3.0)相关;右心室晚期钆增强与复合事件(RR 4.8)及心源性猝死(RR 9.5)相关,其对心源性猝死高风险的识别AUC为0.8、敏感度69%、特异度90%。
要点
- 右心室晚期钆增强患者心源性猝死风险显著升高(RR 9.5,95%CI 4.4-20.5)。
- 右心室晚期钆增强识别心源性猝死高风险AUC 0.8、敏感度69%、特异度90%。
- 右心室收缩功能障碍与复合事件(RR 3.1)及心源性猝死(RR 3.0)相关。
核心结论
- 在已知或疑似心脏结节病患者中,右心室射血分数与右心室晚期钆增强均与不良事件相关,右心室晚期钆增强对识别心源性猝死高风险患者具有良好区分度。
研究设计与样本
- 系统评价与Meta分析,前瞻性注册于PROSPERO(CRD42022302579),检索PubMed、Embase和Web of Science,纳入8项研究共899例已知或疑似心脏结节病患者,平均随访3.2±0.7年,结局为全因死亡、心血管事件或心源性猝死的复合终点。
诊断标准与关键数值
- 右心室收缩功能障碍对复合事件的汇总RR为3.1(95%CI 1.7-5.5,P<0.01),对心源性猝死事件的汇总RR为3.0(95%CI 1.3-7.0,P<0.01)。
临床应用与阅片要点
- 右心室晚期钆增强患者复合事件RR为4.8(95%CI 2.4-9.6,P<0.01),心源性猝死RR为9.5(95%CI 4.4-20.5,P<0.01),均高于无右心室晚期钆增强患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Left ventricular abnormalities in cardiac sarcoidosis (CS) are associated with adverse cardiovascular events, whereas the prognostic value of right ventricular (RV) involvement found on cardiac magnetic resonance is unclear.
OBJECTIVES: This study aimed to systematically assess the prognostic value of right ventricular ejection fraction (RVEF) and RV late gadolinium enhancement (LGE) in known or suspected CS.
METHODS: This study was prospectively registered in PROSPERO (CRD42022302579). PubMed, Embase, and Web of Science were searched to identify studies that evaluated the association between RVEF or RV LGE on clinical outcomes in CS. A composite endpoint of all-cause death, cardiovascular events, or sudden cardiac death (SCD) was used. A meta-analysis was performed to determine the pooled risk ratio (RR) for these adverse events. The calculated sensitivity, specificity, and area under the curve with 95% CIs were weighted and summarized.
RESULTS: Eight studies including a total of 899 patients with a mean follow-up duration of 3.2 ± 0.7 years were included. The pooled RR of RV systolic dysfunction was 3.1 (95% CI: 1.7-5.5; P < 0.01) for composite events and 3.0 (95% CI: 1.3-7.0; P < 0.01) for SCD events. In addition, CS patients with RV LGE had a significant risk for composite events (RR: 4.8 [95% CI: 2.4-9.6]; P < 0.01) and a higher risk for SCD (RR: 9.5 [95% CI: 4.4-20.5]; P < 0.01) than patients without RV LGE. Furthermore, the pooled area under the curve, sensitivity, and specificity of RV LGE for identifying patients with CS who were at highest SCD risk were 0.8 (95% CI: 0.8-0.9), 69% (95% CI: 50%-84%), and 90% (95% CI: 70%-97%), respectively.
CONCLUSIONS: In patients with known or suspected CS, RVEF and RV LGE were both associated with adverse events. Furthermore, RV LGE shows good discrimination in identifying CS patients at high risk of SCD.
引用
- Wang J, Zhang J, Hosadurg N, et al. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2023. PMID: 36752447. doi:10.1016/j.jcmg.2022.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。